Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study

BACKGROUND AND AIM: MDM4, a negative regulator of the p53 tumor suppression pathway, has been demonstrated to be overexpressed in a variety of human cancers. Research has revealed that the rs4245739 A>C polymorphism of MDM4 in the 3’-untranslated region makes it a miR-191 target site, leading to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Asian Pac J Cancer Prev
Egile Nagusiak: Khanlou, Ziba Mohammad, Pouladi, Nasser, Feizi, Mohammadali Hosseinpour, Pedram, Negar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: West Asia Organization for Cancer Prevention 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494227/
https://ncbi.nlm.nih.gov/pubmed/28547953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.4.1133
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak